These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 4058790)

  • 1. A comparative study of choline acetyltransferase from normal and Alzheimer brain.
    Bruce G
    Neurosci Lett; 1985 Aug; 59(2):171-5. PubMed ID: 4058790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Choline acetyltransferase immunohistochemistry in brains of Alzheimer's disease patients and controls.
    Nagai T; McGeer PL; Peng JH; McGeer EG; Dolman CE
    Neurosci Lett; 1983 Apr; 36(2):195-9. PubMed ID: 6866327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced cortical choline acetyltransferase activity in senile dementia of Alzheimer type is not accompanied by changes in vasoactive intestinal polypeptide.
    Rossor M; Fahrenkrug J; Emson P; Mountjoy C; Iversen L; Roth M
    Brain Res; 1980 Nov; 201(1):249-53. PubMed ID: 7417838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased affinity of choline acetyltransferase for choline in Alzheimer's disease: a steady-state kinetic study.
    Nordström O; Eliaz M; Bartfai T; Gottfries CG
    Brain Res; 1987 Sep; 420(2):371-4. PubMed ID: 3676768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular characterization of choline acetyltransferase from bovine brain caudate nucleus and some immunological properties of the highly purified enzyme.
    Malthe-Sørenssen D; Lea T; Fonnum F; Eskeland T
    J Neurochem; 1978 Jan; 30(1):35-46. PubMed ID: 413884
    [No Abstract]   [Full Text] [Related]  

  • 6. Choline acetyltransferase. Purification procedure and factors affecting chromatographic properties and enzyme stability.
    Cozzari C; Hartman BK
    J Biol Chem; 1983 Aug; 258(16):10013-9. PubMed ID: 6885755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Choline acetyltransferase activity in omental tissue.
    Goldsmith HS; Marquis JK; Siek G
    Br J Neurosurg; 1987; 1(4):463-6. PubMed ID: 3268142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [3H]Kainic acid binding and choline acetyltransferase activity in Alzheimer's dementia.
    Pearce BR; Bowen DM
    Brain Res; 1984 Sep; 310(2):376-8. PubMed ID: 6488028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurotransmitter enzyme abnormalities in senile dementia. Choline acetyltransferase and glutamic acid decarboxylase activities in necropsy brain tissue.
    Perry EK; Gibson PH; Blessed G; Perry RH; Tomlinson BE
    J Neurol Sci; 1977 Nov; 34(2):247-65. PubMed ID: 144789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cortical somatostatin-like immunoreactivity in cases of Alzheimer's disease and senile dementia of the Alzheimer type.
    Davies P; Terry RD
    Neurobiol Aging; 1981; 2(1):9-14. PubMed ID: 6115327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regional brain 5-hydroxytryptamine levels are reduced in senile Down's syndrome as in Alzheimer's disease.
    Yates CM; Simpson J; Gordon A
    Neurosci Lett; 1986 Apr; 65(2):189-92. PubMed ID: 2940479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain choline acetyltransferase activity and neuropeptide Y concentrations in Alzheimer's disease.
    Foster NL; Tamminga CA; O'Donohue TL; Tanimoto K; Bird ED; Chase TN
    Neurosci Lett; 1986 Jan; 63(1):71-5. PubMed ID: 3754039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Qualitative abnormalities of choline acetyltransferase in Alzheimer type dementia.
    Koshimura K; Kato T; Tohyama I; Nakamura S; Kameyama M
    J Neurol Sci; 1986 Dec; 76(2-3):143-50. PubMed ID: 3794747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cholinergic innervation of the amygdaloid complex in the human brain and its alterations in old age and Alzheimer's disease.
    Emre M; Heckers S; Mash DC; Geula C; Mesulam MM
    J Comp Neurol; 1993 Oct; 336(1):117-34. PubMed ID: 8254109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Membrane-bound choline acetyltransferase from human brain: purification and properties.
    Peng JH; McGeer PL; McGeer EG
    Neurochem Res; 1986 Jul; 11(7):959-71. PubMed ID: 3748278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aging, Alzheimer's disease, and the cholinergic system of the basal forebrain.
    McGeer PL; McGeer EG; Suzuki J; Dolman CE; Nagai T
    Neurology; 1984 Jun; 34(6):741-5. PubMed ID: 6539435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pre- and postsynaptic neurochemical alterations in Alzheimer's disease.
    Reisine TD; Yamamura HI; Bird ED; Spokes E; Enna SJ
    Brain Res; 1978 Dec; 159(2):477-81. PubMed ID: 215272
    [No Abstract]   [Full Text] [Related]  

  • 18. Choline acetyltransferase immunoreactivity in neuritic plaques of Alzheimer brain.
    Armstrong DM; Bruce G; Hersh LB; Terry RD
    Neurosci Lett; 1986 Nov; 71(2):229-34. PubMed ID: 2431362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of brain choline acetyltransferase activity in Alzheimer's disease, multi-infarct dementia, and combined dementia.
    Rinne JO; Säkö E; Paljärvi L; Mölsä PK; Rinne UK
    J Neural Transm; 1988; 73(2):121-8. PubMed ID: 3210004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regional difference in the kinetics of choline acetyltransferase in brains of neurologically normal elderly people and those with Alzheimer-type dementia.
    Koshimura K; Nakamura S; Miwa S; Fujiwara M; Kameyama M
    J Neurol Sci; 1988 Apr; 84(2-3):141-6. PubMed ID: 3379442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.